Last year Vice interviewed an anonymous chemist/ neuropharmacologist who invented a few new designer drugs similar to ketamine or PCP, most notably methoxetamine which is becoming increasingly popular. Sort of the Alexander Shulgin of disassociatives.
On the medicinal uses of ketamine:
I discovered a long time ago that ketamine and cannabinoids helped my phantom hand. I’m quite convinced these classes work by distorting body image so severely that you phase out triggers for the pain. I have experienced profound proprioceptive distortions after intramuscular PCP injection, as if my whole body were a proportional model of the sensory homunculus. But in a sense, what I feel is not hallucination or a distortion, I actually find dissociatives corrective, that is, they make the phantom disappear. This is not just an idiosyncratic response on my part; there are at least three articles published on the effectiveness of ketamine in treating phantom-limb pain. It’s dished out by British pain-management clinics for just that purpose in the form of a nauseatingly artificial lemon-flavored linctus. Needless to say, the whole lot of it gets squirted up the arse to bypass my taste buds, but even this has its drawbacks… like sticky, sugary bum cheeks!
On being hospitalized after going into a catatonic state while testing 3-MeO-PCP:
And what happened when you were released?
That was the final straw for my partner, and she said she would not sit idly by and watch me self-destruct. When I came home she was gone, Nesbitt was still dead, and all of the arylcyclohexylamines I had been researching had been confiscated and destroyed.
That’s really terrible. Alexander Shulgin always felt that the dissociatives had no use as psychotherapeutic drugs, and John Lilly found that even when you think the effects of ketamine have worn off there is a lingering undercurrent of dissociation that prevents you from reaching baseline.
And despite the fact that I knew all of that, I still ignored what should have been indicators that I was slipping. The arylcyclohexylamines light up too many of the reward systems in the brain, with the dopamine-reuptake inhibition, the NMDA antagonism, and the µ-opioid affinity. They lend themselves to abuse and escape to fantasy. I used to find myself raving about chemicals I had only tried once or twice, saying they were Huxley’s soma or moksha, or Polidamma’s Nepenthe. I’ve come to realize that dissociatives have a really dark side to them that classic serotonergic psychedelics don’t.
Vice: Interview with a Ketamine Chemist
Vice’s interview with Shulgin.
This interview with former Process Church of the Final Judgement member Timothy Wyllie where he talks about PCP.